Sebastien Czernichow
Overview
Explore the profile of Sebastien Czernichow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
244
Citations
5445
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Disse E, Aron-Wisnewsky J, Jacobi D, Clement K, Laville M, Gauthier C, et al.
Diabetes Metab
. 2025 Feb;
51(3):101625.
PMID: 39971183
Aim: - To describe baseline characteristics and safety data of real-world use of semaglutide 2.4 mg. Methods: - Patients with a body mass index (BMI) ≥40 kg/m and at least...
2.
Czernichow S, Rassy N, Carette C, Shoung N, Hu F, Rives-Lange C
Obes Rev
. 2025 Jan;
e13890.
PMID: 39866032
Introduction: Currently, trials are investigating the efficacy of nutrient-stimulated hormone-based therapies (NuSHs) in promoting weight loss in people living with overweight and obesity. However, the extent to which nutritional and...
3.
Pers Y, Nguyen C, Borie C, Daste C, Kirren Q, Lopez C, et al.
Ann Phys Rehabil Med
. 2024 Nov;
67(7):101883.
PMID: 39490291
Background: Although non-pharmacological therapies for knee osteoarthritis (OA) are essential pillars of care, they are often poorly considered and inconsistently applied. Objectives: Under the umbrella of the French Society of...
4.
Bliddal H, Bays H, Czernichow S, Hemmingsson J, Hjelmesaeth J, Hoffmann Morville T, et al.
N Engl J Med
. 2024 Oct;
391(17):1573-1583.
PMID: 39476339
Background: Weight reduction has been shown to alleviate symptoms of osteoarthritis of the knee, including pain. The effect of glucagon-like peptide-1 receptor agonists on outcomes in knee osteoarthritis among persons...
5.
Czernichow S, Ziegler O, Clement K, Coupaye M, Laville M
Lancet
. 2024 Oct;
404(10463):1642-1643.
PMID: 39461787
No abstract available.
6.
Renard D, Tuffet S, Dieude P, Claudepierre P, Gossec L, Fautrel B, et al.
Joint Bone Spine
. 2024 Sep;
92(1):105778.
PMID: 39303938
Objectives: To investigate dietary practices and beliefs of patients with rheumatic and musculoskeletal diseases (RMDs) and associated factors. Methods: In 2019-2020, a cross-sectional multicentre study enrolled patients with inflammatory arthritis...
7.
Goeau-Brissonniere M, Rives-Lange C, Phan A, Kourti E, Rassy N, Lu E, et al.
Diabetes Obes Metab
. 2024 Aug;
26(11):5488-5491.
PMID: 39169527
No abstract available.
8.
Ossima A, Brzustowski A, Paradis V, Van Beers B, Postic C, Laouenan C, et al.
Clin Diabetes Endocrinol
. 2024 Apr;
10(1):9.
PMID: 38659082
Background & Aims: Despite its high prevalence in the western world metabolic dysfunction-associated steatotic liver disease (MASLD) does not benefit from targeted pharmacological therapy. We measured healthcare utilisation and identified...
9.
Bachelot G, Lamaziere A, Czernichow S, Faure C, Racine C, Levy R, et al.
Asian J Androl
. 2024 Apr;
26(4):349-355.
PMID: 38624205
Many lifestyle factors, such as nutritional imbalance leading to obesity, metabolic disorders, and nutritional deficiency, have been identified as potential risk factors for male infertility. The aim of this study...
10.
Carette C, Okamba-Belle D, Hirlemann M, Wack M, Domenge O, Jannot A, et al.
Obes Facts
. 2024 Apr;
17(3):296-302.
PMID: 38583425
Introduction: Heart failure (HF) is difficult to diagnose in obese patients because of cardiovascular and pulmonary comorbidities associated with physical deconditioning, all of which lead to dyspnea. Methods: The OLECOEUR...